{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,4]],"date-time":"2026-05-04T10:24:28Z","timestamp":1777890268957,"version":"3.51.4"},"reference-count":20,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"2","license":[{"start":{"date-parts":[[2017,3,1]],"date-time":"2017-03-01T00:00:00Z","timestamp":1488326400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2016,10,27]],"date-time":"2016-10-27T00:00:00Z","timestamp":1477526400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["elsevier.es","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2017,3]]},"DOI":"10.1016\/j.pbj.2016.12.004","type":"journal-article","created":{"date-parts":[[2017,2,4]],"date-time":"2017-02-04T23:15:34Z","timestamp":1486250134000},"page":"59-62","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":11,"title":["Prevalence of abacavir-associated hypersensitivity syndrome and HLA-B*5701 allele in a Portuguese HIV-positive population"],"prefix":"10.1097","volume":"2","author":[{"given":"Fabr\u00edcia","family":"Carolino","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Natacha","family":"Santos","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Carmela","family":"Pi\u00f1eiro","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ana Sofia","family":"Santos","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pedro","family":"Soares","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ant\u00f3nio","family":"Sarmento","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Josefina Rodrigues","family":"Cernadas","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","reference":[{"key":"R1-5-20210317","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1097\/00130832-200108000-00006","article-title":"HIV and drug allergy.","volume":"1","author":"Pirmohamed","year":"2001","journal-title":"Curr Opin Allergy Clin Immunol"},{"key":"R2-5-20210317","doi-asserted-by":"crossref","first-page":"826","DOI":"10.1016\/j.jaci.2007.10.021","article-title":"Diagnosis and management of HIV drug hypersensitivity.","volume":"121","author":"Davis","year":"2008","journal-title":"J Allergy Clin Immunol"},{"key":"R4-5-20210317","doi-asserted-by":"crossref","first-page":"1502","DOI":"10.1016\/S0149-2918(02)80057-1","article-title":"The abacavir hypersensitivity reaction: a review.","volume":"24","author":"Clay","year":"2002","journal-title":"Clin Ther"},{"key":"R5-5-20210317","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1001\/jama.292.2.180","article-title":"Efficacy and safety of emtricitabine vs stavudine in combination therapy in antiretroviral-naive patients: a randomized trial.","volume":"292","author":"Saag","year":"2004","journal-title":"JAMA"},{"key":"R6-5-20210317","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1111\/j.1365-2125.2010.03784.x","article-title":"Hypersensitivity reactions to HIV therapy.","volume":"71","author":"Chaponda","year":"2011","journal-title":"Br J Clin Pharmacol"},{"key":"R7-5-20210317","doi-asserted-by":"crossref","first-page":"2171","DOI":"10.1345\/aph.1E202","article-title":"Updated clinical risk factor analysis of suspected hypersensitivity reactions to abacavir.","volume":"38","author":"Cutrell","year":"2004","journal-title":"Ann Pharmacother"},{"key":"R8-5-20210317","doi-asserted-by":"crossref","first-page":"1603","DOI":"10.1016\/S0149-2918(01)80132-6","article-title":"Hypersensitivity reactions during therapy with the nucleoside reverse transcriptase inhibitor abacavir.","volume":"23","author":"Hetherington","year":"2001","journal-title":"Clin Ther"},{"key":"R9-5-20210317","first-page":"48","article-title":"Prevalence of HLA-B5701 and its relationship with abacavir hypersensitivity reaction in Iranian HIV-infected patients.","volume":"15","author":"Baniasadi","year":"2016","journal-title":"Tanaffos"},{"key":"R10-5-20210317","doi-asserted-by":"crossref","first-page":"2223","DOI":"10.1097\/00002030-200211080-00017","article-title":"Utility of patch testing in patients with hypersensitivity syndromes associated with abacavir.","volume":"16","author":"Phillips","year":"2002","journal-title":"AIDS"},{"key":"R11-5-20210317","doi-asserted-by":"crossref","first-page":"1092","DOI":"10.1016\/j.jaci.2015.03.019","article-title":"Pharmacogenetics of abacavir hypersensitivity: a systematic review and meta-analysis of the association with HLA-B57:01.","volume":"136","author":"Sousa-Pinto","year":"2015","journal-title":"J Allergy Clin Immunol"},{"key":"R12-5-20210317","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1097\/FPC.0b013e3283390666","article-title":"An epidemiologic study to determine the prevalence of the HLA-B5701 allele among HIV-positive patients in Europe.","volume":"20","author":"Orkin","year":"2010","journal-title":"Pharmacogenet Genomics"},{"key":"R13-5-20210317","doi-asserted-by":"crossref","first-page":"568","DOI":"10.1056\/NEJMoa0706135","article-title":"HLA-B5701 screening for hypersensitivity to abacavir.","volume":"358","author":"Mallal","year":"2008","journal-title":"N Engl J Med"},{"key":"R14-5-20210317","doi-asserted-by":"crossref","first-page":"1027","DOI":"10.1177\/135965350701200708","article-title":"External quality assessment of HLA-B5701 reporting: an international multicentre survey.","volume":"12","author":"Hammond","year":"2007","journal-title":"Antivir Ther"},{"key":"R15-5-20210317","doi-asserted-by":"crossref","first-page":"879","DOI":"10.1590\/abd1806-4841.20132323","article-title":"Patch tests.","volume":"88","author":"Lazzarini","year":"2013","journal-title":"An Bras Dermatol"},{"key":"R16-5-20210317","doi-asserted-by":"crossref","first-page":"1019","DOI":"10.1177\/135965350801300814","article-title":"Refining abacavir hypersensitivity diagnoses using a structured clinical assessment and genetic testing in the Swiss HIV Cohort Study.","volume":"13","author":"Rauch","year":"2008","journal-title":"Antivir Ther"},{"key":"R17-5-20210317","doi-asserted-by":"crossref","first-page":"229","DOI":"10.2165\/00128071-200203040-00001","article-title":"Cellular and molecular pathophysiology of cutaneous drug reactions.","volume":"3","author":"Pichler","year":"2002","journal-title":"Am J Clin Dermatol"},{"key":"R18-5-20210317","doi-asserted-by":"crossref","first-page":"554","DOI":"10.1038\/nature11147","article-title":"Immune self-reactivity triggered by drug-modified HLA-peptide repertoire.","volume":"486","author":"Illing","year":"2012","journal-title":"Nature"},{"key":"R19-5-20210317","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1016\/S0140-6736(02)07873-X","article-title":"Association between presence of HLA-B5701, HLA-DR7, and HLA-DQ3 and hypersensitivity to HIV-1 reverse-transcriptase inhibitor abacavir.","volume":"359","author":"Mallal","year":"2002","journal-title":"Lancet"},{"key":"R20-5-20210317","doi-asserted-by":"crossref","first-page":"1121","DOI":"10.1016\/S0140-6736(02)08158-8","article-title":"Genetic variations in HLA-B region and hypersensitivity reactions to abacavir.","volume":"359","author":"Hetherington","year":"2002","journal-title":"Lancet"},{"key":"R21-5-20210317","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1016\/S0149-2918(02)85132-3","article-title":"Risk factor analysis of hypersensitivity reactions to abacavir.","volume":"24","author":"Symonds","year":"2002","journal-title":"Clin Ther"}],"container-title":["Porto Biomedical Journal"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/api.elsevier.com\/content\/article\/PII:S2444866416301180?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/api.elsevier.com\/content\/article\/PII:S2444866416301180?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.lww.com\/10.1016\/j.pbj.2016.12.004","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,7,23]],"date-time":"2022-07-23T14:45:07Z","timestamp":1658587507000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/02054639-201703000-00005"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,3]]},"references-count":20,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2017]]}},"URL":"https:\/\/doi.org\/10.1016\/j.pbj.2016.12.004","relation":{},"ISSN":["2444-8664"],"issn-type":[{"value":"2444-8664","type":"print"}],"subject":[],"published":{"date-parts":[[2017,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Prevalence of abacavir-associated hypersensitivity syndrome and HLA-B*5701 allele in a Portuguese HIV-positive population","name":"articletitle","label":"Article Title"},{"value":"Porto Biomedical Journal","name":"journaltitle","label":"Journal Title"},{"value":"http:\/\/dx.doi.org\/10.1016\/j.pbj.2016.12.004","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 PBJ-Associa\u00e7\u00e3o Porto Biomedical\/Porto Biomedical Society. Published by Elsevier Espa\u00f1a, S.L.U.","name":"copyright","label":"Copyright"}]}}